CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy

QR Code

CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy

Background Use of CYP2C19 genotyping to guide antiplatelet therapy is associated with improved clinical outcomes in patients naïve to P2Y12 inhibitors undergoing percutaneous coronary intervention. The relationship between CYP2C19 genotype and clinical outcomes in patients on maintenance clopidogrel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rajiv C. Patel, Cameron D. Thomas, Joseph S. Rossi, Francesco Franchi, Ellen C. Keeley, Amber L. Beitelshees, Julio D. Duarte, Luis Ortega‐Paz, Natasha Kulick, Marshall Winget, Anh B. Nguyen, William E. Yang, Sanjay Venkatesh, Dominick J. Angiolillo, Larisa H. Cavallari, Craig R. Lee, George A. Stouffer
Format:	Article
Language:	English
Published:	Wiley 2025-07-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	ACS clopidogrel genotyping MACE PCI
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.125.041634
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accuracy of Machine Learning Models for Early Prediction of Major Cardiovascular Events Post Myocardial Infarction: A Systematic Review and Meta-Analysis
by: Yi Xiang, et al.
Published: (2025-06-01)

CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME PATIENTS WITH CYP2Y12*2 AND CYP2Y12*3 POLYMORPHISMS
by: R. Rahmatini, et al.
Published: (2018-04-01)

Factors Associated with 30-day Major Adverse Cardiovascular Event in Acute Coronary Syndrome Patients with Non-Dialysis Chronic Kidney Disease: A Retrospective Cohort Study
by: Eka Ginanjar, et al.
Published: (2023-03-01)

Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy
by: Yu Wu, et al.
Published: (2025-12-01)

THE PROTOCOL: INFLUENCE OF THE COMBINATION CARRIAGE СУР2С19*2 AND *17 ON EFFICACY OF CLOPIDOGREL
by: Е. М. Zelenskaya, et al.
Published: (2017-11-01)

Clopidogrel therapy in acute coronary syndrome: Contemporary issues
by: Satyavir Yadav, et al.
Published: (2025-07-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

The study of structural-mechanical characteristics of suppositories with clopidogrel
by: Ye. А. Redkina, et al.
Published: (2018-10-01)

Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
by: Priyadharshini Ananthathandavan, et al.
Published: (2024-12-01)

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Comparative study of specific activity of rectal suppositories with clopidogrel
by: I. L. Kechyn, et al.
Published: (2021-12-01)

The study of excipients’ influence on Clopidogrel releasing from the rectal suppositories
by: Ye. А. Redkina, et al.
Published: (2018-03-01)

Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS
by: L. I. Buriachkovskaia, et al.
Published: (2016-01-01)

COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET AGGREGATION: ObSERVATIONAL STUDY
by: A. S. Skotnikov, et al.
Published: (2018-05-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Clopidogrel effects on thrombolysis effectiveness and clinical course of ST elevation myocardial infarction (30-day follow-up)
by: S. V. Shalaev, et al.
Published: (2007-08-01)

Impact of Multiple Cardiovascular Events on Long‐Term Outcomes and Bleeding Risk in Patients With Acute Coronary Syndrome: A Nationwide Population‐Based Cohort Study
by: Chih‐Wei Chen, et al.
Published: (2025-07-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01)

The 7-step “P” technique: a novel manual push method for high-quality OCT imaging in severe coronary stenosis
by: Jincheng Guo, et al.
Published: (2025-07-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon
by: Xinyi Yan, et al.
Published: (2025-10-01)

Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
by: Aviad Rotholz, et al.
Published: (2025-07-01)

Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study
by: Mario Šafer, et al.
Published: (2025-05-01)

Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention
by: Dunya Habeeb Shnain, et al.
Published: (2024-06-01)

Advances in the Clinical Use of Clopidogrel: A Review of Individualized Treatment Strategies and Monitoring Optimization Based on Genetic Polymorphisms
by: Dou N, et al.
Published: (2025-07-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Meteorological drought using the Precipitation Condition Index in dry northeast Mexico during the 2000-2023 period
by: Víctor H. Domínguez-Meza, et al.
Published: (2025-06-01)

Coronary Angiography Optimized by Optical Coherence Tomography in Patients with Coronary Artery Disease
by: Klara Đambić, et al.
Published: (2025-07-01)

Medical Therapy Versus Percutaneous Coronary Intervention in Patients with Myocardial Bridging from a National Population-Based Cohort Study: The Use of Big Data Analytics
by: Chayakrit Krittanawong, et al.
Published: (2025-04-01)

Clopidogrel therapy effects on cell hemostasis in acute coronary syndrome
by: R. A. Rakhimova, et al.
Published: (2008-12-01)

Clopidogrel monotherapy is associated with higher mortality risk compared to aspirin: a retrospective analysis of NHANES 1999–2018
by: Tieshi Zhu, et al.
Published: (2025-12-01)